Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #799
- Final score
- 33.76
- Years on list
- 6
↗ Climbed 101 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 101 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 307 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 199 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | UTHR | SHC | EXEL |
|---|---|---|---|
| Climate Change | 30.5 | 36.6 | 24.5 |
| Employee Relations | 42.1 | 36.1 | 44.8 |
| Environment | 26.2 | 38.1 | 46.2 |
| Stakeholders & Society | 48.4 | 18.3 | 28.6 |
| Human Rights | 6.3 | 44.5 | 6.3 |
| Governance | 42.8 | 23.1 | 28.1 |
| Performance Rating | 47.1 | 46.8 | 49.1 |